ArticlePharmaceuticals (Basel, Switzerland)2021

Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice.

Geng-Ruei Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.